F. Torres, G. Calvo, and C. Pontes. Medicina clínica, (December 2005)4826<m:linebreak></m:linebreak>JID: 0376377; ppublish;<m:linebreak></m:linebreak>Disseny; Regulació.
A. Dasgupta, K. Lawson, and J. Wilson. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 67 (16):
1337-43(August 2010)5997<m:linebreak></m:linebreak>JID: 9503023; ppublish; Exemples interessants<m:linebreak></m:linebreak>Tests d'equivalència.
I. Group. European journal of clinical investigation, 40 (1):
69-86(January 2010)5648<m:linebreak></m:linebreak>JID: 0245331; ppublish;<m:linebreak></m:linebreak>Recursos/Organització; Recerca clínica; Polítiques de recerca.
A. Kesselheim, C. Robertson, J. Myers, S. Rose, V. Gillet, K. Ross, R. Glynn, S. Joffe, and J. Avorn. The New England journal of medicine, 367 (12):
1119-27(September 2012)6941<m:linebreak></m:linebreak>GR: 2R25CA092203-08/CA/NCI NIH HHS/United States; GR: K08HS18465-01/HS/AHRQ HHS/United States; JID: 0255562; CIN: N Engl J Med. 2012 Sep 20;367(12):1152-3. PMID: 22992081; ppublish;<m:linebreak></m:linebreak>Publicació; Interpretació de resultats; Indústria; RCT.
M. Maclure, B. Carleton, and S. Schneeweiss. Medical care, 45 (10 Supl 2):
S44-9(October 2007)6352<m:linebreak></m:linebreak>GR: AG19463/AG/NIA NIH HHS/United States; JID: 0230027; 0 (Cyclooxygenase 2 Inhibitors); ppublish;<m:linebreak></m:linebreak>CER.